New approaches in the therapy of breast cancer — introduction Robert B. DicksonMarc E. Lippman Introduction Pages: 1 - 2
Inhibition of signaling from Type 1 receptor tyrosine kinases via intracellular expression of single-chain antibodies Roger R. BeerliWinfried WelsNancy E. Hynes Immunotherapy Pages: 11 - 17
Preclinical testing of an anti-erbB-2 recombinant toxin C. Richter KingPhilip G. KasprzykNancy A. Turner Immunotherapy Pages: 19 - 25
Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer Jeffrey SchlomJudy KantorJ. Michael Hamilton Immunotherapy Pages: 27 - 39
The multifunctional role of transforming growth factor (TGF)-ßs on mammary epithelial cell biology Carlos L. ArteagaTeresa C. DuggerStephen D. Hurd Tumor growth pathways and their inhibition Pages: 49 - 56
The significance ofheregulin in breast cancer tumor progression and drug resistance R. LupuM. CardilloC. Tang Tumor growth pathways and their inhibition Pages: 57 - 66
Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines A. E. WakelingA. J. BarkerJ. R. Woodburn Tumor growth pathways and their inhibition Pages: 67 - 73
Farnesyltransferase inhibitors and anti-Ras therapy Jackson B. GibbsNancy E. KohlAllen Oliff Tumor growth pathways and their inhibition Pages: 75 - 83
The efficacy of 9-cis retinoic acid in experimental models of cancer Marco M. GottardisWilliam W. LamphRichard A. Heyman Tumor growth pathways and their inhibition Pages: 85 - 96
Breast cancer angiogenesis — new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting Adrian L. HarrisHuatang ZhangRoy Bicknell Tumor-host interactions Pages: 97 - 108
Inhibition of fibroblast growth factors Anton WellsteinFrank Czubayko Tumor-host interactions Pages: 109 - 119
Antimetastatic action of the prostacyclin analogue cicaprost in experimental mammary tumors Martin R. SchneiderMichael SchirnerHerrmann Graf Tumor-host interactions Pages: 133 - 141